Take the Next Step

Enter your email address to stay informed with the latest information about portfolio monitoring

Magnifying Glass

Check for Losses!

Kaplan Fox has the experience, skills, and resources to aggressively pursue our clients' rights on issues of securities fraud.

Contact Us to Start

Current Case Investigations

The Advisory Board Company

September 6, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating The Advisory Board Company ("Advisory Board” or the "Company") (NASDAQ: ABCO), a company that provides performance-improvement software and services to the healthcare and education industries.  Investors who purchased shares of Advisory Board common stock may be affected.

SteadyMed Ltd.

September 1, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of SteadyMed Ltd. (“SteadyMed” or the “Company”) (NASDAQ: STDY).

DryShips Inc.

September 1, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DryShips Inc. (“DryShips” or the “Company”) (NASDAQ: DRYS).

Envision Healthcare Corporation

August 22, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Envision Healthcare Corporation (“Envision Healthcare” or the “Company”) (NYSE: EVHC).

Sequans Communications S.A.

August 22, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Sequans Communications S.A. (“Sequans” or the “Company”) (NYSE:  SQNS).

American Public Education

August 10, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of American Public Education, Inc. (“American Public Education” or the “Company”) (NASDAQ APEI).  Investors who purchased shares of American Public Education securities may be affected.

Load More

Settlement Filing Deadlines

Company Ticker Class Period Deadline Administrator
Xencor, Inc. XNCR On behalf of all former holders of Xencor, Inc.'s (the "Company") Series A-E preferred stock whose shares were converted to A-1 stock in the Recapitalization. 5/13/17 Strategic Claims Services  
Molycorp, Inc. MCP 2/21/2012 - 10/15/2013 5/18/17 Angeion Group  
Health Enhancement Products, Inc. (N/K/A Zivo Bioscience, Inc.) HEPI 10/31/2003 - 5/31/2004 5/18/17 Rust Consulting, Inc.  
Barclays Bank PLC (Electronic Foreign Exchange Trading - BARX) n/a 6/1/2008 - 4/21/2016 5/19/17 Garden City Group  
EZCORP, Inc. EZPW 4/19/2012 - 10/6/2014 5/19/17 Garden City Group  
King Digital Entertainment plc KING 3/26/2014 - 9/22/2014 5/23/17 Gilardi & Co.  
Load More